Bactrim and Atrioventricular block second degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block second degree is reported as a side effect among people who take Bactrim (sulfamethoxazole; trimethoprim), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Kaletra, and have Hiv infection.

The phase IV clinical study analyzes which people have Atrioventricular block second degree when taking Bactrim. It is created by eHealthMe based on reports of 86,509 people who have side effects when taking Bactrim from the FDA, and is updated regularly.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.

What is Atrioventricular block second degree?

Atrioventricular block second degree (heart block second degree) is found to be associated with 377 drugs and 818 conditions by eHealthMe. Check the latest studies of Atrioventricular block second degree.

On Jul, 20, 2026

86,509 people reported to have side effects when taking Bactrim.
Among them, 18 people (0.02%) have Atrioventricular block second degree.

Could Bactrim cause Atrioventricular block second degree?

Among these 18 people:

How long have people been on Bactrim when they have Atrioventricular block second degree? *

What is the gender of people who have Atrioventricular block second degree when taking Bactrim? *

female: 38.89 %
male: 61.11 %

What is the age of people who have Atrioventricular block second degree when taking Bactrim? *

What are other drugs people take besides Bactrim? *

What are other side effects people have besides Atrioventricular block second degree? *

Nausea (feeling of having an urge to vomit): 9 people, 50.00%
Chest Pain: 9 people, 50.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 8 people, 44.44%
Atrioventricular Block Complete (heart block complete): 6 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 33.33%
Atrioventricular Block First Degree (heart block first degree): 5 people, 27.78%
Kawasaki's Disease (an autoimmune disease in which the medium-sized blood vessels throughout the body become inflamed): 4 people, 22.22%
Cardiotoxicity (damage to the heart muscle): 3 people, 16.67%
Cardiac Arrest: 3 people, 16.67%
Cardiac Failure Congestive: 3 people, 16.67%

What are the existing conditions these people have? *

Hiv Infection: 3 people, 16.67%
Rashes (redness): 2 people, 11.11%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 11.11%
Stress And Anxiety: 1 person, 5.56%
Nausea And Vomiting: 1 person, 5.56%
Nausea (feeling of having an urge to vomit): 1 person, 5.56%
High Blood Cholesterol: 1 person, 5.56%
Depression: 1 person, 5.56%
Cardiac Failure Congestive: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Bactrim and have Atrioventricular block second degree?

- Check whether Atrioventricular block second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bactrim:

Bactrim (89,117 reports)

Atrioventricular block second degree treatments and more:

Atrioventricular block second degree (4,079 reports)

How severe was Atrioventricular block second degree and when was it recovered:

Atrioventricular block second degree in Bactrim

Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:

Atrioventricular block second degree and drugs with ingredients of sulfamethoxazole; trimethoprim (45 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (377 drugs)

Browse all the conditions that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (818 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Bactrim) and Bactrim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.